glp 1 and dpp4 DPP-4 inhibitors GLP-1RAs: cardiovascular safety and benefits | Military Medical Research Frontiers | Clinical Use of
Description
2016;11(3):e0150967
The growing prevalence of obesity and associated comorbidities, such as diabetes and cardiovascular disorders, has propelled the demand for GLP-1 receptor agonists
The fewer doses of medication per day for our diabetes patients, the better
Understanding your dosing in practical terms matters when you are drawing medication into a syringe
Looking ahead, we see advanced HILIC-based methods playing an increasingly crucial role in analyzing highly polar peptides and their impurities, which can be difficult to separate using conventional reversed-phase LC
By contrast, GLP-1Rexpressing neurons in the DVC appear to be a critical site of action for GLP-1RAinduced anorexia and weight loss
